GLP 1 THERAPIES

May 22 2026SCIENCE

New Path for Obesity Drugs: A Small Company’s Big Idea

SureNano Science, a Canadian biotech firm, is stepping into the fast‑growing world of GLP‑1 medicines that help people lose weight and control blood sugar. These drugs, like Ozempic and Wegovy, have already made huge profits, so big pharma is scrambling to create the next hit. SureNano wants to comp

reading time less than a minute